<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mahmud Yusef Yusef Ismaeel</style></author><author><style face="normal" font="default" size="100%">Herryawan RE Dyari</style></author><author><style face="normal" font="default" size="100%">Nazlina Ibrahim</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Protein from Phaleria macrocarpa Fruit Aqueous Extract Inhibits Early and Late Replication Phases of Human Herpes Virus Type-1</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">39-45</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; &lt;em&gt;Phaleria macrocarpa&lt;/em&gt; fruit is known to have protein but the antiviral activity potential has not been explored.&lt;strong&gt; Objective: &lt;/strong&gt;To determine the antiviral activity of &lt;em&gt;Phaleria macrocarpa&lt;/em&gt; fruit protein aqueous extract (PMFPAE) and the fractions against human herpesvirus type 1 (HHV-1). &lt;strong&gt;Methods: &lt;/strong&gt;Protein from &lt;em&gt;P. macrocarpa&lt;/em&gt; fruit aqueous extract was precipitated using ammonium sulphate and followed by fractionation on Sephadex G-25. Cytotoxicity was determined in Vero cells and followed by determination of antiviral activity by plaque reduction assay against a clinical strain of HHV-1. Effect of PMFPAE on virus replication was determined in pre-treatment, time-addition and time-removal assays. &lt;strong&gt;Results:&lt;/strong&gt; PMFPAE and its fractions were non-cytotoxic to Vero cells with 50% cytotoxic concentration (CC&lt;sub&gt;50&lt;/sub&gt;) values ranged between 96 ± 1.3 to 1450 ± 2 μg/mL. PMFPAE have good anti-HHV-1 activity with Selective Index (SI) of 80.6 but reduces in fractions P&lt;sub&gt;1 &lt;/sub&gt;to P&lt;sub&gt;6&lt;/sub&gt; ranging between 4.2 and 67.9. Fractions with high SI were P&lt;sub&gt;1&lt;/sub&gt; and P2 contained high molecular weight (MW) proteins and P&lt;sub&gt;6 &lt;/sub&gt;has the lowest MW suggestively peptides. Treatment with PMFPAE to host cells prior to virus infection had little effect on inhibiting HHV-1 replication. Treatment with PMFPAE affects virus early and late replication phase with plaque inhibition percentage increased during 10&lt;sup&gt;th &lt;/sup&gt;to 16&lt;sup&gt;th&lt;/sup&gt; hour post-infection. &lt;strong&gt;Conclusion:&lt;/strong&gt; PMFPAE contained non-cytotoxic proteins that affects HHV-1 early and late replication phases. Proteins with high antiviral activity resides in fractions with high MW and very low MW peptides.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Key words:&lt;/strong&gt; Phaleria macrocarpa fruit protein, Fractionation, Cytotoxicity, Anti-Human herpes virus type-1.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">39</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Mahmud Yusef Yusef Ismaeel&lt;sup&gt;1,2&lt;/sup&gt;, Herryawan RE Dyari&lt;sup&gt;3&lt;/sup&gt;, Nazlina Ibrahim&lt;sup&gt;1&lt;/sup&gt;,*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, MALAYSIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Medical Science, Abbs Community College, Hajjah, YEMEN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Earth Science and Environmental, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, MALAYSIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Noor Zarina Abd Wahab</style></author><author><style face="normal" font="default" size="100%">Aziah Azizul</style></author><author><style face="normal" font="default" size="100%">Norhidayah Badya</style></author><author><style face="normal" font="default" size="100%">Nazlina Ibrahim</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antiviral Activity of an Extract from Leaves of the Tropical Plant Cynometra cauliflora</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">(3-(4</style></keyword><keyword><style  face="normal" font="default" size="100%">5-dimethylthiazol-2-yl)-2</style></keyword><keyword><style  face="normal" font="default" size="100%">5-diphenyltetrazolium bromide); virucidal.</style></keyword><keyword><style  face="normal" font="default" size="100%">Cynometra cauliflora</style></keyword><keyword><style  face="normal" font="default" size="100%">Herpes simplex virus type 1</style></keyword><keyword><style  face="normal" font="default" size="100%">plaque reduction assay</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">752-757</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;&lt;em&gt;Cynometra cauliflora&lt;/em&gt; is a species of tree in the family Fabaceae and has been used in folk medicinal preparation. &lt;strong&gt;Objectives:&lt;/strong&gt; In this study, &lt;em&gt;Cynometra cauliflora &lt;/em&gt;methanolic leaves extract was tested against clinical isolate herpes simplex virus type-1 (HSV-1). &lt;strong&gt;Materials and Methods: &lt;/strong&gt;The leaves of &lt;em&gt;C. cauliflora&lt;/em&gt; plant was extracted using methanol extraction method. Cytotoxicity was assessed using 3-(4,5-dimethylthiazol-2,5-diphenyltetrazolium bromide (MTT) assay. Plaque reduction assays were carried out to evaluate the antiviral activity of&lt;em&gt; C. cauliflora&lt;/em&gt; extract against HSV-1. These include post-treatment, pre-treatment and virucidal assays. &lt;strong&gt;Results:&lt;/strong&gt; The value of cytotoxic concentration, CC&lt;sub&gt;50&lt;/sub&gt; of&lt;em&gt; C. cauliflora&lt;/em&gt; extract was 36 mg/ mL. High antiviral activity was observed in post-treatment. &lt;em&gt;C. cauliflora &lt;/em&gt;extract treatment was found to not interfere directly to infectious particle and confer mild protection when given as prophylaxis. &lt;strong&gt;Conclusion:&lt;/strong&gt; This study provides important novel insights on the phytomedicinal properties of &lt;em&gt;C. cauliflora&lt;/em&gt; extracts on HSV-1.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">752</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Noor Zarina Abd Wahab&lt;sup&gt;1,&lt;/sup&gt;*, Aziah Azizul1, Norhidayah Badya&lt;sup&gt;2&lt;/sup&gt;, Nazlina Ibrahim&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;br /&gt;
&lt;sup&gt;1&lt;/sup&gt;Department of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Terengganu, MALAYSIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, Universiti Sultan Zainal Abidin, Terengganu, MALAYSIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan, Bangi, MALAYSIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Syaza Safia Fouzi</style></author><author><style face="normal" font="default" size="100%">Noor Zarina Abd Wahab</style></author><author><style face="normal" font="default" size="100%">Leong Chee Yan</style></author><author><style face="normal" font="default" size="100%">Nazlina Ibrahim</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Styrylpyrone Derivative from Goniothalamus sp.: A Powerful Drug for Fighting Against Herpes Simplex Virus Type 1</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiviral</style></keyword><keyword><style  face="normal" font="default" size="100%">Herpes Virus type 1 (HSV-1)</style></keyword><keyword><style  face="normal" font="default" size="100%">in silico approaches</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular docking and Styrylpyrone derivative.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1598-1606</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;The emergence of drug resistance towards Herpes Simplex Virus Type 1 (HSV-1) has encouraged scientists to develop novel lower toxicity and highly effective anti-HSV drugs. Styrylpyrone derivative (SPD) is a bioactive compound isolated from the roots and leaves of Goniothalamus sp. It is believed that this compound possesses antiviral properties against HSV-1. &lt;strong&gt;Objective: &lt;/strong&gt;This paper introduces the interaction of SPD towards HSV-1 through in silico study of molecular docking and molecular dynamic simulation.&lt;strong&gt; Materials and Methods:&lt;/strong&gt; Molecular docking is a computational tool which is used to study the molecular interaction between two or more structures. ADME/T properties of the SPD were generated using the SwissADME online tool in which SPD was found to have a good pharmacokinetic profile. &lt;strong&gt;Results:&lt;/strong&gt; Molecular docking study revealed that SPD has a high docking score of -7.9 Kcal/mol. SPD has a strong affinity with the thymidine kinase (PDB id: 1OF1) producing hydrogen bond and non-polar interaction at the target point of amino acid residue. &lt;strong&gt;Conclusion:&lt;/strong&gt; Molecular docking analysis provides new insight into the structure-based design of SPD compounds with better antiviral activity against HSV-1.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1598</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Syaza Safia Fouzi&lt;sup&gt;1&lt;/sup&gt;, Noor Zarina Abd Wahab&lt;sup&gt;2&lt;/sup&gt;, Leong Chee Yan&lt;sup&gt;1&lt;/sup&gt;, Nazlina Ibrahim&lt;sup&gt;1&lt;/sup&gt;,*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biological Science and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, MALAYSIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, 21300 Kuala Nerus, Terengganu, MALAYSIA&lt;/p&gt;
</style></auth-address></record></records></xml>